Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor
Author:
Funder
Division of Cancer Prevention, National Cancer Institute
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://insight.jci.org/articles/view/127098/files/pdf
Reference61 articles.
1. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration
2. Twenty-five year follow-up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study
3. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group
4. Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group
5. Loss of heterozygosity for chromosomes 16q and 1p in Wilms’ tumors predicts an adverse outcome;Grundy;Cancer Res,1994
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comprehensive overview of liquid biopsy applications in pediatric solid tumors;npj Precision Oncology;2024-08-03
2. Insights into Personalized Care Strategies for Wilms Tumor: A Narrative Literature Review;Biomedicines;2024-06-30
3. Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities;Pediatric Blood & Cancer;2024-03-31
4. Recent progress in mass spectrometry-based urinary proteomics;Clinical Proteomics;2024-02-22
5. Progress towards Therapies for Solid Renal Tumors in Children;Advances in Clinical Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3